Megna Michael R sold KNSA
October 30, 2026 · Form 4 insider transaction
Megna Michael R sold 5,350 shares of Kiniksa Pharmaceuticals International, plc at $97.74 per share, a transaction worth $522.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,350
Price
$97.74
Total value
$522.9K
InsiderMegna Michael R
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateOctober 30, 2026
Filing dateNovember 3, 2026
Shares owned after12,697
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 30, 2026.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $97.60 and $98.48. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.